Related Experiment Videos
Chromosomal alterations in atherosclerotic plaques.
L Matturri1, A Cazzullo, P Turconi
1Institute of Pathology, University of Milan, Ospedale Maggiore, IRCCS, Milan, Italy.
Atherosclerosis
|March 21, 2001
Summary
Chromosome 7 and 11 alterations and FGF-3 gene amplification are linked to unstable atherosclerosis plaques. These genetic changes may drive plaque progression and complications.
Area of Science:
- Cardiovascular Biology
- Genetics
- Pathology
Background:
- Atherosclerosis progression involves complex cellular and genetic changes.
- Alterations in chromosomes 7 and 11 have been implicated in cardiovascular disease.
Purpose of the Study:
- To investigate chromosome 7 and 11 alterations and FGF-3 gene amplification in carotid endarterectomy specimens.
- To correlate these genetic changes with plaque stability in atherosclerosis.
Main Methods:
- Analysis of 23 carotid endarterectomy specimens.
- Utilized histological staining, immunophenotyping, and fluorescence in situ hybridization (FISH).
- Examined chromosomes 7, 11, and FGF-3 gene status in stable and unstable plaques.
Main Results:
- Unstable plaques (n=18) showed trisomy and tetrasomy of chromosome 7, monosomy of chromosome 11, and FGF-3 gene amplification.
- Stable plaques (n=5) and normal arterial walls exhibited no chromosomal alterations.
- Chromosome 3 ploidy remained normal across all sample types.
Conclusions:
- Chromosome 7 and 11 alterations and FGF-3 gene amplification are associated with unstable atherosclerotic plaques.
- These genetic anomalies may play a role in the transition of stable to complicated plaques.
- Findings suggest potential biomarkers for plaque instability and cardiovascular risk.